Comparing Oncology Pharma (OTCMKTS:ONPH) and VTEX (NYSE:VTEX)

VTEX (NYSE:VTEX) and Oncology Pharma (OTCMKTS:ONPH) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

Valuation and Earnings

This table compares VTEX and Oncology Pharma”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VTEX	$220.54 million	5.65	-$13.69 million	($0.04)	-169.25
Oncology Pharma	N/A	N/A	N/A	N/A	N/A

Oncology Pharma has lower revenue, but higher earnings than VTEX.

Institutional & Insider Ownership

63.7% of VTEX shares are owned by institutional investors. 40.9% of VTEX shares are owned by company insiders. Comparatively, 18.0% of Oncology Pharma shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Volatility & Risk

VTEX has a beta of 1.39, indicating that its share price is 39% more volatile than the S&P 500. Comparatively, Oncology Pharma has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings for VTEX and Oncology Pharma, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VTEX	0	0	5	0	3.00
Oncology Pharma	0	0	0	0	N/A

VTEX presently has a consensus price target of $10.40, indicating a potential upside of 53.62%.

Profitability

This table compares VTEX and Oncology Pharma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
VTEX	1.51%	1.36%	0.97%
Oncology Pharma	N/A	N/A	N/A

Summary

VTEX beats Oncology Pharma on 8 of the 8 factors compared between the two stocks.

About VTEX

VTEX provides software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce strategy, including building online stores, integrating, and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It has operations in Brazil, Argentina, Chile, Colombia, France, Italy, Mexico, Peru, Portugal, Romania, Singapore, Spain, the United Kingdom, and the United States. VTEX was founded in 2000 and is headquartered in London, the United Kingdom.

About Oncology Pharma

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.